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Background: Routine HIV testing accompanied with pre-exposure prophylaxis (PrEP) requires innovative support in a real-world
setting.
Objective: This study aimed to determine the usage of HIV self-testing (HIVST) kits and their secondary distribution to partners
among men who have sex with men (MSM) in China, who use PrEP, in an observational study between 2018 and 2019.
Methods: In 4 major cities in China, we prospectively followed-up MSM from the China Real-world oral PrEP demonstration
study, which provides daily or on-demand PrEP for 12 months, to assess the usage and secondary distribution of HIVST on
quarterly follow-ups. Half of the PrEP users were randomized to receive 2 HIVSTs per month in addition to quarterly facility-based
HIV testing. We evaluated the feasibility of providing HIVST to PrEP users.
Results: We recruited 939 MSM and randomized 471 to receive HIVST, among whom 235 (49.9%) were daily and 236 (50.1%)
were on-demand PrEP users. At baseline, the median age was 29 years, 390 (82.0%) men had at least college-level education,
and 119 (25.3%) had never undergone facility-based HIV testing before. Three months after PrEP initiation, 341 (74.5%) men
had used the HIVST provided to them and found it very easy to use. Among them, 180 of 341 (52.8%) men had distributed the
HIVST kits it to other MSM, and 132 (51.6%) among the 256 men who returned HIVST results reported that used it with their
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sexual partners at the onset of intercourse. Participants on daily PrEP were more likely to use HIVST (adjusted hazard ratio=1.3,
95% CI 1.0-1.6) and distribute HIVST kits (adjusted hazard ratio=1.3, 95% CI 1.1-1.7) than those using on-demand PrEP.
Conclusions: MSM who used PrEP had a high rate of usage and secondary distribution of HIVST kits, especially among those
on daily PrEP, which suggested high feasibility and necessity for HIVST after PrEP initiation. Assuming that fourth-generation
HIVST kits are available, HIVST may be able to replace facility-based HIV testing to a certain extent.
Trial Registration: Chinese Clinical Trial Registry ChiCTR1800020374; https://www.chictr.org.cn/showprojen.aspx?proj=32481
International Registered Report Identifier (IRRID): RR2-10.1136/bmjopen-2019-036231
(J Med Internet Res 2021;23(8):e23978) doi: 10.2196/23978
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Introduction
Oral pre-exposure prophylaxis (PrEP) can reduce HIV infections
among adherent men who have sex with men (MSM) [1-3].
While the adherence to PrEP is only approximately 60% in the
real-world setting [4], it is crucial for all PrEP users to undergo
quarterly HIV testing to avoid a breakthrough infection and
acquiring resistance to antiretroviral therapy [5].
However, the implementation of PrEP has increased the rate of
missing facility-based testing. Almost 30% of PrEP users did
not show up for their first quarterly clinical visits [6], and
approximately 40% of them missed their 6-monthly appointment
[7]. Difficulty attending clinical visits and missing laboratory
testing has become one of the main reasons for the interruption
[8] and discontinuation [9] in PrEP use in clinical settings. Since
the outbreak of COVID-19, attendance at facility-based HIV
testing became more difficult because of clinic closure,
challenges with social distancing, and related difficulties [10].
It is crucial to identify strategies to ensure frequent HIV testing
among individuals on PrEP.
In order to improve and expand PrEP uptake, nonclinical PrEP
approaches are being piloted, such as central dispensing at
pharmacies [11], community venues (eg, automated teller
machines in shopping malls) [12], schools, and prisons or jails
[13]. These approaches still require periodic HIV testing, often
through HIV self-testing (HIVST), and be supplemented with
internet-based support, which is a convenient and confidential
option for HIV testing, allowing people to take an HIV test and
learn the outcome in their own home or at other private locations
[14], while mailing and application of the test kit, support
consultations during testing, uploading of testing outcomes, and
follow-ups can be conducted over the internet [15,16].
HIVST can also promote partner testing through secondary
distribution of test kits [17]; that is, an individual who is
provided multiple self-test kits can distribute them to sexual
partners or to others in their social network [18]. Peers within
the key HIV-infected population play an important role in
facilitating HIV prevention in that population; for example, by
promoting the uptake of HIV testing [19] and linkage to care
[20]. Providing multiple HIVST kits to PrEP users and
encouraging their secondary distribution would potentially
empower MSM using PrEP and the promote HIV prevention
within the MSM community.
HIVST technology has advanced in recent years.
Third-generation HIVST technology has a testing period of 3
weeks, with high sensitivity and specificity [21]. PrEP recipients
can easily administer HIVST at home and know their HIV status
at least 4-8 weeks ahead of their next quarterly HIV
facility-based test, as recommended by World Health
Organization and Centers for Disease Control and Prevention
[5]. In such a scenario, HIVST can be used to identify a
breakthrough infection earlier and prevent 4-8 weeks of
antiretroviral therapy in PrEP that could lead to resistance.
We aimed to assess the usage and secondary distribution of
internet-based HIVST kits and their correlates among MSM
using PrEP, prospectively. This information can provide
evidence regarding the utility of HIVST in the era of PrEP and
support a better paired and targeted HIV-testing strategy among
PrEP users in the future.
Methods
Study Design, Setting, and Participants
We conducted a randomized control trial of HIV self-testing
among MSM who are PrEP users (Chinese Clinical Trial
Registry# ChiCTR1800020374). Participants were recruited
from among MSM in the ongoing PrEP pragmatic trial
(CROPrEP, ChiCTR-IIN-17013762), which provides regimens
of daily and on-demand PrEP, in 4 major Chinese cities (Beijing,
Shenyang, Chongqing, and Shenzhen) from December 2018 to
September 2019. CROPrEP provides all participants standard
care of PrEP, including quarterly facility-based HIV testing.
Given the well-documented protective effect of PrEP, the sample
size of the CROPrEP study at each site was not determined
through power calculations. The sample size at each site was
increased maximally by fully considering the human resources
and capability of each study site [22].
We randomized half of the enrolled PrEP recipients to provide
them 2 HIV self-tests per month, in addition to the standard
care. The study team has generated a service account on one of
the most popular social media in China (WeChat) to provide
web-based services on the application of extra testing kits,
instructions on self-testing, real-time consultation with the staff,
uploading of test outcomes, and follow-up questionnaires. All
HIVST kits distributed or secondarily distributed were marked
with a serial number. Participants who received HIVST were
also encouraged to share them with their male sexual partners.
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All participants were prospectively followed up quarterly. This
study adhered to the STROBE (Strengthening the Reporting of
Observational studies in Epidemiology) checklist (Multimedia
Appendix 1).
The study sites are general hospitals equipped with HIV
voluntary counseling and testing clinics and HIV treatment
clinics with physicians specialized in infectious diseases in 4
major cities in China: The Youan Hospital of Capital Medical
University, Beijing; The First Affiliated Hospital of China
Medical University, Shenyang; The Chongqing Public Health
Medical Center of Southwest University, Chongqing; and The
Third People’s Hospital, Shenzhen.
Participants were eligible to participate in this study if they (1)
were designated male at birth; (2) have sex with male partners;
(3) are aged 18-65 years; (4) report having ≥1 of the following
risk factors in the last 6 months: (a) had condomless receptive
anal sex with a male partner, (b) had more than 2 male sexual
partners, (c) had self-reported sexually transmitted infections
(STIs) such as syphilis, gonorrhea, chlamydia, chancroid, or
lymphogranuloma venereum, or (d) have ever used postexposure
prophylaxis medication, but have not received postexposure
prophylaxis medication in the previous month; (5) have a
nonreactive outcome on a fourth-generation HIV enzyme-linked
immunosorbent assay test at baseline screening and undetectable
HIV-1 RNA; (6) have no evidence of severe liver or kidney
dysfunction on a comprehensive evaluation (including physical
examination, urine test, and blood biochemical examination);
and (7) indicate willingness to participate and sign an informed
consent form. Individuals were excluded if they (1) are deemed
ineligible on eligibility evaluation for the CROPrEP trial, (2)
refuse to accept or use the HIVST kits (with reasons recorded),
or (3) refuse to sign the informed consent form.
To prevent loss to follow-up bias, the clinicians and study staff
provided one-on-one personalized compliance support,
counseling, and cohort maintenance during the follow-up period.
Furthermore, community-based organizations and the weekly
internet-based retention strategies were used to strengthen group-
and individual-level supervision of retention and cohort
management. This internet-based strategy included interactive
peer counseling focusing on study retention; a short message
providing routine follow-up visit reminders, along with a live
chat.
Measures
Information on demographic characteristics (including age,
education level, marital status, and monthly income),
HIV-related risk behavior in the past 3 months (frequency of
anal intercourse, and instances of condomless anal intercourse,
substance abuse, etc), and testing history for HIV and STIs in
the past were collected at baseline through self-administrated
questionnaires distributed on each participants’ smartphone.
The aforementioned information was obtained in accordance
with a systematic review that analyzed studies on HIV testing
behaviors among MSM in China [23]. Participants were grouped
into <25-year-old and ≥25-year-old age groups in accordance
with the definition of youth of the United Nations [24].
Participants were also grouped by their median monthly income.
Measures of monthly income were separated by the median
income. Usage of HIVST and secondary distribution of HIVST
to male sexual partners and other MSM were recorded at
quarterly follow-up among all participants through
self-administrated questionnaires on each participants’
smartphone. The returned results of photographs of used HIVST
were uploaded by participants after they used HIVST kits, and
information regarding the place, occasion, and ease of using
HIVST was collected. The proportion of HIVST usage was
calculated among participants retained at the third month
follow-up visit. Furthermore, the proportion of HIVST
secondary distribution was calculated among participants who
had self-reported usage of HIVST at the third month follow-up
visit.
Statistical Analyses
Statistical analysis was conducted using SPSS (version 20.0,
IBM Corp). Demographics, the PrEP regimen, and HIV-related
risk behavior in the past 3 months among all participants were
expressed as numbers and percentages. Follow-up time was
determined as the number of days from the date of enrollment
to the date of quarterly follow-up. Univariable and multivariable
Cox regression analyses were performed to assess the predictors
of self-reported usage of HIVST and secondary distribution of
HIVST at the first quarterly follow-up. Variables with P<.20
on univariable analysis were included in the multivariable model
to avoid the omission of clinically relevant variables, which had
an underestimated effect in univariable analysis [25,26].
Variables in the final model were selected with a forward
stepwise procedure. Hazard ratios (HRs) and adjusted HRs
(aHRs) were calculated. On multivariate analysis, P<.05 was
considered the cut-off for a significant difference. We plotted
Kaplan–Meier survival curves for predictors for HIVST usage
and their secondary distribution during multivariable Cox
regression analysis with P<.05 indicating significance.
Ethics Approval
The study protocol was approved by the ethics review board of
the First Affiliated Hospital of China Medical University
(IRB-2018-273), Shenyang. Written informed consent was
obtained from each participant before collecting study
information or blood samples. Participants voluntarily
participated in the study and had the right to refuse to answer
any question. Participants had the right to withdraw from the
study without penalty. The protocols for the CROPrEP trial [25]
and this study [27] have been published. This HIVST study
among PrEP recipients was registered on the Chinese Clinical
Trial Registry (trial ID ChiCTR1800020374).
Results
Baseline Demographics and Behavioral Characteristics
A total of 939 MSM were recruited from the CROPrEP trial,
with 470 daily PrEP users and 469 on-demand PrEP users. In
total, 471 men were randomized to receive 2 HIV self-tests per
month, in addition to the standard care, which included 235
(49.0%) daily PrEP users and 236 (50.1%) on-demand PrEP
users.
The median age of these 471 participants at baseline was 29
years (quantile 25-35 years); among them, 390 (82.0%) had an
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education level of undergraduate and above, 241 (51.2%) had
a monthly income of less than US $857, and 266 (56.5%) were
single. Regarding HIV-related risk behavior in the past 3
months, 165 (35.0%) individuals had had anal intercourse every
week and 234 (49.7%) had had anal intercourse every month,
312 (66.2%) of them had condomless anal intercourse with male
sexual partners, 226 (48.0%) used Poppers in the previous 3
months, and 103 (22.5%) had participated in group sex. In total,
39 (8.3%) of them self-reported having STI-related symptoms
in the previous 12 months. Further, 375 (79.6%) participants
self-reported having used HIVST in the past, and 352 (74.7%)
reported having undergone facility-based HIV testing in the
past (Table 1).
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81 (17.2)Senior high and below
390 (82.8)Undergraduate and above





30 (6.4)Married or cohabiting with a female
175 (37.2)In a relationship or cohabitating with a male




64 (13.6)Less than once a month
Had condomless anal intercourse in the previous 3 months
312 (66.2)Yes
159 (33.8)No
Had used Poppers in the previous 3 months
226 (48.0)Yes
245 (52.0)No
Had group sex in the previous 3 monthsa
103 (22.5)Yes
354 (77.5)No
Had sexually transmitted infection–related symptoms in the previous 12 months
39 (8.3)Yes
432 (91.7)No
Have ever used HIV self-testing in the past
375 (79.6)Yes
96 (20.4)No
Have ever undergone facility-based HIV testing in the past
352 (74.7)Yes
119 (25.3)No
aThere were 14 missing data.
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Usage, Returning Results, and Sharing of HIVST at
the First Quarterly Follow-ups
Among these 471 men, 458 men were retained at the first
quarterly follow-up, resulting in a retention rate of 97.2%. At
the first quarterly of PrEP initiation, a total of 341 (74.5%)
participants self-reported that they had used the HIVST in the
past 3 months, among whom 256 (75.1%) returned HIVST
testing outcomes by uploading photographs of the used HIVST
kits marked with a serial number. In total, 260 (76.2%) men
self-reported that they had recommended HIVST to their male
sexual partners or gay friends, and 180 (52.8%) participants
self-reported that they had shared their HIVST kits with the
male sexual partners or gay friends. Among the 256 participants
who had returned HIVST outcomes, the most frequent place of
using HIVST was at home (n=218, 85.2%). In total, 132 (51.6%)
men reported that HIVST was used immediately before or after
sexual intercourse with their male sexual partners (Figure 1).
Figure 1. Study flow diagram. HIVST: HIV self-testing.
Correlation of Self-Reported Usage of HIVST on
Quarterly Follow-up
On univariable Cox regression analysis, men with the following
variables were more likely to use HIVST during follow-up:
being on daily PrEP (vs on-demand PrEP, HR=1.273, 95% CI
1.028-1.576; P=.03), having an education level of senior high
or below (vs college and above, HR=1.393, 95% CI 1.054-1.841;
P=.02), having STI-related symptoms in the previous 12 months
(vs not having symptoms, HR=1.384, 95% CI 0.956-2.004;
P=.09), having ever used HIVST in the past (vs having used
HIVST in the past, HR=1.492, 95% CI 1.102-2.020; P=.01).
Participants with the following variables were less likely to use
HIVST: having had anal intercourse every day in the past 3
months (vs less than once a month, HR=0.396, 95% CI
0.143-1.101; P=.08), having had condomless anal intercourse
in the past 3 months (vs not having had condomless anal
intercourse, HR=0.825, 95% CI 0.687-0.990; P=.04) (Table 2).
After the forward stepwise procedure, all variables with P<.20
on univariable regression analysis were included in the
multivariable regression model, and participants with the
following variables were more likely to use HIVST during
follow-ups: being on daily PrEP (vs on-demand PrEP,
aHR=1.298, 95% CI 1.047-1.608; P=.02), having an education
level of senior high or below (vs undergraduate and above,
aHR=1.482, 95% CI 1.119-1.964; P=.006), and having used
HIVST in the past (vs not having used HIVST in the past,
aHR=1.642, 95% CI 1.205-2.242; P=.002). Furthermore,
participants who self-reported having used Poppers in the past
3 months (vs those not having used Poppers in the past 3 months,
aHR=0.788, 95% CI 0.633-9.981; P=.03) were less likely to
use HIVST (Table 2 and Figure 2).
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Table 2. Cox regression model of correlates of usage of HIV self-testing among pre-exposure prophylaxis recipients within 3 months of treatment
initiation in 4 major cities in China (N=471).
Secondary distribution of HIV self-test kitsUsage of HIV self-testingVariable
P value
Adjusted hazard









































Currently married (vs single)




















Less than once a month
——.33———.040.825
(0.687-0.990)
Had condomless anal intercourse

















Had sexually transmitted infec-

















HIV testing in the past
aVariables with P<.20 on univariable analysis were included in the multivariable Cox regression model.
b—: not determined.
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Figure 2. Kaplan–Meier survival curves for predictors of HIVST usage. HIVST: HIV self-testing, PrEP: pre-exposure prophylaxis.
Correlation of Secondary Distribution of HIVST Kits
at Quarterly Follow-up
On univariable Cox regression analysis, participants with the
following variables were more likely to secondarily distribute
HIVST kits during follow-up: being on daily PrEP (vs
on-demand PrEP, HR=1.343, 95% CI 1.072-1.682; P=.01),
being currently married (vs being single, HR=1.523, 95% CI
0.963-2.408; P=.07), having ever used HIVST in the past (vs
having never used HIVST in the past, HR=1.415, 95% CI
1.034-1.937; P=.03) (Table 2).
After the stepwise forward procedure, all variables with P<.20
on univariable regression were included in the multivariable
regression model, and participants with following variables
were more likely to secondarily distribute HIVST during
follow-ups: being on daily PrEP (vs on-demand PrEP,
aHR=1.352, 95% CI 1.079-1.694; P=.009), being currently
married (vs single, aHR=1.706, 95% CI 1.074-2.709; P=.02),
and having used HIVST in the past (vs not having used HIVST
in the past, aHR=1.464, 95% CI 1.066-2.009 P=.02) (Figure
3).
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Figure 3. Kaplan–Meier survival curves for predictors of HIVST secondary distribution. HIVST: HIV self-testing; PrEP: pre-exposure prophylaxis.
Discussion
Principal Findings
We prospectively identified a high rate of usage and secondary
distribution of the internet-based HIVST among MSM who are
using PrEP in a multicenter pragmatic trial in China, especially
among the daily PrEP users. This result warrants the
internet-based HIVST as a crucial part of the HIV testing
strategy paired with PrEP among the MSM population.
Furthermore, the high rate of secondary distribution of HIVST
kits and self-testing among sexual partners among PrEP users
assures a promising future for peer-initiated expanded HIV
testing and maximization of the HIV prevention among the
MSM community.
Approximately 80% of PrEP users have used HIVST within 3
months after PrEP initiation and found it easy to use, reflecting
HIV testing behavior among PrEP recipients. Every 4 of 5 of
these PrEP users had used HIVST before the initiation of PrEP,
which is much higher than the level among the general MSM
population in China (20%-40%) [28,29]. Since difficulty
attending facility-based testing was one of the main reasons for
discontinuing PrEP during implementation [8,9], this high usage
of HIVST among PrEP users warrants future consideration of
substituting some facility-based HIV testing during PrEP and
provides evidence in support of HIVST to support PrEP users
during the COVID-19 pandemic in the future, since
facility-based services and in-person patient-clinician contact
has been limited because of the pandemic [30].
Notably, there was a high rate of secondary distribution of
HIVST and testing of sexual partners among those who had
used HIVST after PrEP initiation. Half of the HIVST was used
to test together with their sexual partners immediately before
or after intercourse. This is significant because of the limited
success and high cost of accessing MSM at clinics or
provider-initiated expanded HIV testing strategies [31,32].
According to previous studies, MSM who accept or uptake PrEP
were more concerned about their partners’ HIV status [33] and
had more sexual partners [34], which makes them excellent
facilitators for expanded HIV testing among the MSM
population. Empowering them with HIVST as a tool to
undertake secondary distribution and partner testing can
maximize the impact of PrEP on the MSM community via
peer-initiated HIV prevention campaigns. Future studies should
vigorously pursue and explore the critical role of PrEP users in
HIV prevention within the key populations.
Factors promoting the usage and secondary distribution of
HIVST among PrEP users were also identified. Men on daily
PrEP were more likely to use and secondarily distribute HIVST
after PrEP initiation than those on the on-demand regimen.
Since most of the HIVST was used immediately before or after
sexual intercourse, this correlation can be explained by the fact
that MSM on daily PrEP displayed more frequent HIV-related
risk behavior and a higher number of sexual partners [35,36].
J Med Internet Res 2021 | vol. 23 | iss. 8 | e23978 | p. 9https://www.jmir.org/2021/8/e23978
(page number not for citation purposes)
Zhang et alJOURNAL OF MEDICAL INTERNET RESEARCH
XSL•FO
RenderX
According to HIV transmission network studies, MSM with a
higher number of sexual partners are associated more firmly
with other MSM and had a crucial impact on the network of
HIV transmission within the population. This correlation
illustrates that MSM on daily PrEP play a more critical role in
expanded HIV testing and HIV prevention campaigns as peers
among the MSM community. Studies on the social network of
PrEP recipients built through HIVST distribution should be
actively pursued in the future.
An inhibitor of the use of HIVST among PrEP users is the use
of Poppers, which is one of the most popular recreational drugs
among MSM worldwide [37]. According to previous studies,
Poppers users are more likely to consider themselves PrEP
candidates and more likely to be a current PrEP user [38].
However, Poppers usage among MSM is associated with an
increased risk of HIV infection [39,40] and a higher probability
of participating in group sex [40], which indicates the necessity
of timely HIV testing. This inhibitor should draw attention from
PrEP providers to address timely HIV testing for PrEP users.
Limitations
This study has several limitations. First, there is no
fourth-generation HIVST kit available currently in China. These
are available in the United Kingdom and in other countries and
would potentially allow this model to replace some of the
facility-based testing. Second, this study was conducted before
the COVID-19 pandemic, which might underestimate the usage
of HIVST among PrEP users. Third, this study only assessed
the usage and secondary distribution within the first 3 months
after PrEP initiation, which requires a longer follow-up period
to illustrate its long-term usage. Finally, this study only included
participants from 4 major cities in China, which did not represent
the general MSM population in China.
Conclusions
Within a pragmatic setting, MSM who are using PrEP had a
high rate of usage and secondary distribution of HIVST kits,
especially among those on daily PrEP. Offering multiple HIVST
to PrEP users to replace some of the facility-based HIV testing
and to facilitate expanded HIV testing is feasible and necessary,
especially during the COVID-19 pandemic.
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